anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

173,701-173,760 of 319,975

filter-aware
01
Slide 1
AbCellera | Results Presentation Deck | 21 slidesAbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Attention1 hit
02
AbCellera | Results Presentation Deck | 21 slidesAbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a background image of lab personnel to reinforce the context of clinical/biotech operations.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Attention1 hit
04
The diagram is a custom funnel/process flow visualization.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
05
The slide uses a grid-like layout to display partner logos and deal details (multi-target/multi-year vs single target, and therapeutic focus).AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
06
The slide uses a radial chart to show therapeutic area distribution and a nested donut/arc to show health focus (human vs animal).AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
07
The chart uses a stacked bar approach to show revenue components over time, with specific callouts for total values of research fees, clinical milestones, and royalties.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
08
The chart uses a timeline axis (3m to 24m) and maps revenue streams to specific development stages.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
09
AbCellera | Results Presentation Deck | 21 slidesAbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
10
The chart uses a box plot to visualize the distribution of royalty rates across two time periods.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
11
The chart is a stacked bar representation of milestone payments by stage.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
12
The chart uses a logarithmic-style vertical axis to show potency differences, with Bebtelovimab as the baseline.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
13
The slide uses visual representations of molecular structures to illustrate the focus areas.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
14
AbCellera | Results Presentation Deck | 21 slidesAbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
15
The slide uses a stacked bar chart to distinguish between programs with and without downstream participation.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
16
The slide provides a snapshot of the company's clinical pipeline as of February 24, 2022.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
17
The chart uses a waterfall-style bridge to connect the segments between years.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a waterfall-style annotation to show the delta between 2020 and 2021 values.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a side-by-side bar chart comparison for three distinct financial metrics.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
20
The chart illustrates the cash flow bridge for the full year 2021.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
21
AbCellera | Results Presentation Deck | 21 slidesAbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
02
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
03
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
04
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
05
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
06
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
07
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
08
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Key Messages1 hit
09
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
10
The slide uses a narrative structure to outline the patient's clinical progression from birth to genetic diagnosis.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Patient Medical History1 hit
11
The slide uses a timeline framework to map clinical events against age in years.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Patient Medical History1 hit
12
The slide uses a narrative structure to explain the diagnostic journey from initial symptoms to definitive genetic confirmation.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
13
The slide uses a before-after framework to demonstrate the efficacy of the treatment plan.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Diagnostic Methods and Biochemistry Labs1 hit
14
The chart tracks patient data from 2007 to 2021 with specific clinical annotations explaining fluctuations.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
15
Clinical case study summary slide.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
16
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Summary and Conclusions1 hit
17
The slide uses a vertical icon-based process flow to connect clinical facts to the conclusion.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
19
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
20
Includes patient photo and clinical data table comparing normal ranges to patient baseline.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
21
The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Pegzilarginase Program OverviewLoop · Jobs To Be Done1 hit
22
The slide uses a process flow diagram to illustrate the clinical trial structure.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
23
The slide uses a combination of medical classification (GMFCS) and functional assessment tools (GMFM, Timed Walk Tests) to quantify mobility.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
24
Clinical trial safety data presentation.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
25
The chart uses box plots to show distribution, with specific clinical guideline and normal range thresholds marked.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
26
The slide highlights the efficacy of pegzilarginase in a clinical setting.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
27
Includes MCID thresholds for GMFM-E (GMFCS I and II).Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
28
Includes study design timeline and MCID thresholds for GMFCS levels.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
29
Includes patient photos as visual evidence of mobility improvement.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
30
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
31
The photo shows a child with a sign that says 'First Day of 4th GRADE' and 'I WANT TO BE A: WARRIOR SEPT. 1st 2021'.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
32
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
33
Contains company logo, address, website, and document reference code.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
01
Slide 1
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
02
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
03
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
04
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
05
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
06
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit